Ensysce Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.41

+0.01 (+3.05%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +9,114.2% upside

Low Target $25.94

Average Target $37.99

High Target $62.46

Current Price $0.41

Current
$0.41

Target
$37.99

$25.94 $37.99 avg $62.46

Scenario Analysis

Bear Case

$25.94

6,191.5%

Low target

Base Case

$37.99

+9,114.2%

Avg target

Bull Case

$62.46

+15,049.2%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$2.75

-85.0% from high

52-Week Low

$0.23

+79.3% from low

Target vs 52W High

$37.99

+1,281.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.7%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.3%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.3%